|This Slide: #85 of 100|
Slide #85. JLL Partners — BioClinica and CoreLab Partners
BioClinica and CoreLab Partners (NASDAQ:BIOC)
BioClinica, Inc. (NASDAQ:BIOC), a leading global provider of clinical trial management solutions, today announced that it has entered into a definitive agreement to be acquired by a holding company controlled by JLL Partners, Inc., a leading private equity firm.
Strong Buy (4.00 out of 4)
(ranked higher than approx. 97% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite